In addition, GATA-3 did not appear to be involved in the upregulation of IL-4 production in CTCL progressing lesions, thus indicating an alternative mechanism responsible for the Th2 profile. The gene discussed is IL4; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.